Western University

Scholarship@Western
Electronic Thesis and Dissertation Repository
12-11-2013 12:00 AM

Exploring the Structure and Biochemistry of Oxidation-Mediated
Inhibitation of the Peptidyl-Prolyl Isomerase PIN1
Brendan T. Innes, The University of Western Ontario
Supervisor: Dr. David Litchfield, The University of Western Ontario
A thesis submitted in partial fulfillment of the requirements for the Master of Science degree in
Biochemistry
© Brendan T. Innes 2013

Follow this and additional works at: https://ir.lib.uwo.ca/etd
Part of the Biochemistry Commons, Molecular Biology Commons, Nervous System Diseases
Commons, and the Structural Biology Commons

Recommended Citation
Innes, Brendan T., "Exploring the Structure and Biochemistry of Oxidation-Mediated Inhibitation of the
Peptidyl-Prolyl Isomerase PIN1" (2013). Electronic Thesis and Dissertation Repository. 1794.
https://ir.lib.uwo.ca/etd/1794

This Dissertation/Thesis is brought to you for free and open access by Scholarship@Western. It has been accepted
for inclusion in Electronic Thesis and Dissertation Repository by an authorized administrator of
Scholarship@Western. For more information, please contact wlswadmin@uwo.ca.

EXPLORING THE STRUCTURE AND BIOCHEMISTRY OF
OXIDATION-MEDIATED INHIBITION OF THE PEPTIDYL-PROLYL
ISOMERASE PIN1
(Thesis format: Monograph)

by

Brendan T. Innes

Graduate Program in Biochemistry

A thesis submitted in partial fulfillment
of the requirements for the degree of
Master of Science

The School of Graduate and Postdoctoral Studies
The University of Western Ontario
London, Ontario, Canada

© Brendan T. Innes, 2013

Abstract
Pin1 is a phosphorylation-dependent peptidyl-prolyl isomerase that has
been shown to be neuroprotective in aging-related neurodegenerative diseases
such as Alzheimer's disease (AD). However, it is not active in AD brain, and a
recent proteomic screen of Mild Cognitive Impairment (MCI) brain samples
revealed that Pin1 is oxidized in the brains of these pre-AD patients. This
suggests that this oxidation may be the cause of the loss of the neuroprotective
Pin1 function in AD. The Pin1 active site contains a functionally critical cysteine
residue (Cys113) with a low predicted pKa, making it highly susceptible to
oxidation. We hypothesize that Pin1 is inhibited by oxidation of this cysteine.
This hypothesis was tested using enzyme activity assays, mutational analysis, and
structural studies. We conclude that the loss of Pin1 activity due to oxidation can
be isolated to the oxidative modification of Cys113, and reveals a potential
mechanism for countering this loss of function.

Keywords
Neurodegeneration, Alzheimer’s disease, Peptidyl-prolyl cis-trans
isomerase Pin1, Oxidation, Redox signaling, Peptidyl-prolyl isomerase assay, Xray crystallography.
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Introduction
The peptidyl-prolyl cis/trans isomerases (PPIases) are a class of enzymes
that catalyze the cis/trans isomerization of the peptide bond preceding a proline
residue. Until the early 1990s, the two families of PPIases, the cyclophilins and
FKBPs, were known for their role in protein folding and chaperone functions, and
the immune responses associated with their respective inhibitors.1,2 The existence
of a third, cyclophilin A- and FK506-insensitive PPIase family, the parvulins, was
confirmed in 1994 by Gunter Fischer's group. In 1996 Tony Hunter's lab
identified a phosphate-directed parvulin interacting with NIMA that was critical
for mitotic regulation and homologous to the essential yeast parvulin Ess1.3-6
This protein, Pin1, became a subject of interest in terms of a number of different
diseases due to the unique nature of its phosphate-directed substrate specificity.

1.1

The biochemistry of the phosphate-directed binding and
isomerase activity of Pin1
Pin1 is an 18 kDa parvulin made up of a 39-residue class IV WW domain

and the catalytic PPIase domain, connected by a short, flexible linker, as shown in
Figure 1-1. Both the WW and PPIase domains exhibit similar specificity for the
phosphorylated target sequence of pSer/Thr-Pro. However, the WW domain, a
small protein-interaction domain named for its two conserved Trp residues, binds
with approximately 10-fold higher affinity to the canonical target peptide Pintide,
while the PPIase domain in isolation was shown to be unable to bind to Pin1
substrates.7 Nevertheless, the PPIase domain does exhibit phosphate-directed
1

binding and has structural elements critical for this function.8 Clearly identified
in the original structure and confirmed by mutagenesis studies performed
previously by the Litchfield lab, the residues Lys63, Arg68 and Arg69 form a
positively charged pocket to coordinate the phosphorylated Ser/Thr, and are
required for binding to most Pin1 substrates.3,9,10 It has been assumed that the
WW domain of Pin1 was responsible for protein targeting and substrate
recognition, with the PPIase domain simply catalysing the isomerization of the
peptide bond. However, it was recently proposed that the two domains may act in
a concerted manner on some substrates by way of binding to multiple sites
simultaneously.9 While the majority of Pin1 substrates have only one known
binding site, a large minority possess multiple sites, and in most cases these sites
are spaced approximately 20 residues apart, potentially allowing the WW domain
to interact with one site, targeting the PPIase domain to isomerize the other. This
has been exemplified by NMR studies of Tau, which has been shown to have two
Pin1 binding sites of similar affinity 19 residues apart, only one of which is
isomerized by Pin1.11,12 In this study, the binding and catalytic activity of fulllength Pin1 was compared to that of the PPIase domain alone on peptides
containing one or both Pin1 binding sites. It was shown that while the WW
domain enhances Pin1 activity when a single pTP site is present on the peptide,
phosphorylation of the second site increased Pin1 binding affinity but decreased
catalytic activity in a WW-domain-dependent manner.11 It is apparent that the
two domains of Pin1 interact in a more complex manner than is suggested by the
classical interpretation of their roles. A better understanding of the regulatory
2

capacity of the WW domain when interacting with Pin1 may help explain some of
the contradictions in its interactions when mediating tumourigenesis.
The Pin1 active site has been known since its crystal structure (1PIN) was
resolved in 1997 by Ranganathan et al.3 Cys113, His59, His157, and Ser154
form a pocket around the peptide bond, lending evidence to the theory that unlike
other PPIases, Pin1 catalyses the isomerization of its substrate through the
formation of a covalently-bound tetrahedral intermediate species, as shown in
Figure 1-2. First, the phosphate group is localized to its binding pocket (as
described above) bringing the peptide bond from 0° to 90°, thereby shifting the
carbonyl oxygen of the substrate such that it no longer prevents the side-chain of
Cys113 from entering the active site. Cys113 is deprotonated by the nearby
His59, allowing nucleophilic attack by the thiolate upon the carbonyl carbon of
the substrate. The resulting negative charge on the carbonyl oxygen is stabilized
by proximity to His157. This high-energy tetrahedral intermediate relaxes back
into cis or trans conformation, and the substrate is released. However, questions
began to be raised regarding this model in 2002 with the publication of a solution
structure of the Arabidopsis thaliana homologue of Pin1 (Pin1At) by Landrieu et
al.13 The NMR data revealed that the C113 analog of Pin1At undergoes little
change upon binding to an active-site ligand, suggesting that a covalent bond is
not formed. Following this, a series of reports from the Litchfield lab tested this
model through mutagenesis and catalytic activity studies, and found it to be
inaccurate. In 2007, Behrsin and colleagues performed a unigenic evolution study
that revealed, among other things, that Cys113 does not act as a nucleophile.10
3

While this residue was conserved in the initial unigenic evolution experiment,
targeted mutation to a serine, which would have maintained its role as a
nucleophile, abolished Pin1 activity, whereas mutation to an aspartic acid
maintained approximately 30% activity. This suggests that a negatively-charged
environment at position 113, rather than a nucleophile, is critical for the Pin1
catalytic mechanism. Further evidence against the classical view was provided by
Bailey et al. the following year, by showing that His59 and His157 were not
required to maintain the hydrogen-bonding network necessary to create the
thiolate nucleophile at Cys113 or stabilize the tetrahedral intermediate, but instead
were critical for maintaining protein stability.14 The critical experiment in this
work was the rescue of the catalytically-inactive H59L mutation by mutating
H157L, the effect of which was to increase protein stability and consequently
enzyme activity. Given the evidence for a negatively-charged environment
around Cys113, Behrsin and colleagues proposed an alternative catalytic
mechanism in 2007 similar to the bond-distortion mechanisms favoured by other
PPIases.10 The chemical environment around Cys113 created by Ser111, Ser115,
and a coordinated water molecule results in a very low predicted pKa for the
residue. This partial negative charge on the Cys113 allows it to stabilize the
double-bond character of the carbonyl group of the substrate, rather than allowing
a resonance structure to form, which would impart double-bond characteristics to
the peptide bond to be isomerized. Further studies regarding active-site chemistry
will improve the understanding of the Pin1 catalytic mechanism, potentially
facilitating development of methods of therapeutic regulation of the enzyme.
4
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Figure 0-1. The peptidyl-prolyl isomerase Pin1 with a substrate dipeptide.
The crystal structure of R14A Pin1 solved as a part of this thesis, with a
phosphoserine-proline substrate dipeptide (backbone carbons in bright yellow)
modelled into the active site based on the location of analogous chemical groups
in the active site inhibitor bound to Pin1 in the crystal structure 2ITK.63 The
backbone trace of Pin1 is coloured to reflect different groups, while the elements
of rendered amino acids are coloured in this and subsequent figures using the
standard colour scheme of oxygen in red, nitrogen in blue, sulphur in yellow, and
phosphorus in orange. The WW domain is shown in purple, with the pink ends of
the backbone trace indicating the start and end of the 12 residue long unresolved
linker region. The isomerase domain is in dark grey, with the catalytic face
highlighted. In green is the hydrophobic pocket, which interacts with the
substrate proline, and in pink is the phosphate binding loop. The blue region is
the catalytic pocket, containing a conserved hydrogen bonding network (shown
with yellow dashed lines).78 Important residues contributing to the functions of
each area are shown.
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Figure 0-2. The various models of the Pin1 catalytic mechanism.
Top left shows the resonance double-bond nature of the peptide bond. The
covalent mechanism is as follows: First, the phosphate group is localized to its
binding pocket, described above, bringing the peptide bond from 0° to 90°,
thereby shifting the carbonyl oxygen of the substrate such that it no longer
prevents the side-chain of Cys113 from entering the active site. Cys113 is
deprotonated by the nearby His59, allowing nucleophilic attack by the thiolate
upon the carbonyl carbon of the substrate. The resulting negative charge on the
carbonyl oxygen is stabilized by proximity to His157. This high-energy
tetrahedral intermediate relaxes back into cis or trans conformation, and the
substrate is released. The non-covalent mechanism is as follows: The chemical
environment around Cys113, created by Ser111, Ser115, and a coordinated water
molecule, results in a very low predicted pKa for the residue. This partial
negative charge on the Cys113 allows it to stabilize the double-bond character of
the carbonyl group of the substrate, rather than allowing a resonance structure to
form, which would impart double-bond characteristics to the peptide bond to be
isomerized. Adapted from Behrsin, et al., 2007.10

8

1.2

Pin1 as a target against proliferative signaling in cancer.
Proline-directed phosphorylation is a subset of cell signalling involved in a

variety of cell processes including cell-cycle regulation. As the only known
phospho-directed peptidyl-prolyl isomerase, Pin1 plays a critical role in mediating
conformational changes involved in these signalling processes and is thus
implicated in pathologies caused by failures in this machinery, such as cancer and
neurodegeneration. Pin1 has been shown to be overexpressed in a wide variety of
cancers, including prostate, lung, ovarian, cervical, brain tumours, and melanoma,
and that heightened protein levels correlate with poorer clinical outcomes in
prostate cancer.15-17 While Pin1 positively regulates a number of oncogenes and
inhibits some tumor suppressors, its most apparent oncogenic role is in Her2/Neuor Ras-mediated tumours.18 Mouse models have demonstrated that
overexpression of Pin1 enhances Neu and Ras oncogenicity, while Pin1-null mice
are Neu and Ras resistant.19,20 Both these proteins upregulate the transcription
factor E2F, which in turn upregulates both Pin1 and cyclin D1. Pin1 interacts
with cyclin D1, preventing its export from the nucleus and subsequent targeting to
the proteasome.20 Furthermore, Pin1 enhances cyclin D1 transcription by
facilitating upstream signalling factors. Pin1 interacts with phosphorylated Jun
N-terminal kinases, allowing them to phsophorylate c-Jun and subsequently
trigger transcription of cyclin D1.17 Pin1 interaction with β-catenin prevents its
turnover and targets it to the nucleus, thereby activating transcription of cyclin
D1.21 Finally, Pin1 isomerizes the p65/RelA binding site of NfκB, thereby
freeing it from its inhibitor and allowing it to accumulate in the nucleus,
9

enhancing transcription of cyclin D1.22 Cyclin D1 drives cell cycle progression
and enhances E2F transcription, creating a positive feedback loop mediated by
Pin1 that is used by the oncogenes Her2/Neu and Ras to promote proliferation in a
variety of cancers. Thus, it is clear that Pin1 could serve as a novel therapeutic
target for the treatment of these cancers.

1.3

The loss of Pin1 activity is implicated in the development of
neurodegenerative disease.
The loss of Pin1 activity is has been suggested as a causative factor in a

variety of age-related neurodegenerative pathologies. While Pin1-null mice
display no apparent developmental phenotype and show lower onset and
increased resistance to some types of tumour formation, they do show signs of
aging much earlier than their wild-type counterparts, including neuronal
degeneration.23,24 In fact, the loss of Pin1 function has been proposed as a
causative factor in Alzheimer's disease (AD), a neurodegenerative disease that
results in large-scale loss of neurons in the hippocampus, the brain region
responsible for memory. Post-mortem diagnosis of AD is based on the presence
of two molecular pathologies, intracellular neurofibrillary tangles (NFT) and
extracellular β-amyloid (Aβ) plaques, both of which can be mitigated by Pin1
activity.25,26 Hyperphosphorylation of the microtubule-binding protein Tau has
been implicated in the formation of NFT. Pin1 binds to at least one
phosphorylation site on Tau, and can reverse this loss of microtubule binding,
thereby preventing aggregation of the protein.27,28 Conversely, if Pin1 is not
10

available to mediate isomerization at this site, phosphorylation triggers misfolding
of Tau, allowing the pathological aggregates to form.29 β-Amyloid (Aβ) plaques
are amyloids formed by the deposition of the insoluble Aβ42 peptide
extracellularly. Aβ42 is produced by the sequential processing of the transmembrane amyloid precursor protein (APP) by β- and γ-secretases. This
processing is mediated by phosphorylation of APP at Thr668, but as with Tau,
Pin1-mediated isomerization at this site prevents pathogenic cleavage.23
The concentration of Pin1 in neuronal cells is reduced and its normal
subcellular localization to the nucleus is aberrant in Alzheimer’s disease.30,31
These early studies suggested that Pin1 expression is reduced in AD and this
reduction fuels the progression of AD pathologies, such as AB plaques and NFT,
that would have otherwise been prevented by Pin1. However, these studies never
directly measured Pin1 expression levels (ie. by qPCR of Pin1 mRNA), instead
drawing this conclusion based on the reduced concentration of soluble Pin1 in AD
neurons. Spurred on by the spread of this conclusion to a number of reviews,32-37
a number population studies of the effect of Pin1 promoter polymorphisms on AD
onset and progression were undertaken. These studies were not able to draw a
genetic link between Pin1 and Alzheimer’s disease progression, nor show that
Pin1 expression is decreased in AD.38-42 A more likely explanation for the loss of
soluble Pin1 in AD stems from its interaction with the insoluble cellular infarcts
characteristic of AD, Aβ plaques and NFT. Studies have shown that Pin1
associates with both neurofibrillary tangles and amyloid plaques; this causes a
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reduction in the soluble fraction of Pin1 and a change in the localization from the
nucleus to the cytoplasm.43,44
Since Pin1 isomerase activity has been shown to mitigate the development
of both Aβ plaques and NFT, there must be a different mechanism causing the
loss of Pin1 function prior to the development of AD. Mild Cognitive Impairment
(MCI) is considered a precursor to Alzheimer’s disease 45. Recent redox
proteomic analysis of hippocampal samples from both MCI and AD patients has
shown increased levels of oxidative stress in these patients and identified Pin1 as
oxidized in both diseases.46,47 Pin1 is shown to have less isomerase activity in
hippocampal samples of MCI and AD patients than age-matched controls, thus it
was hypothesized that oxidation of Pin1 resulted in loss of function and
subsequent development of neurodegenerative infarcts. The hypothesized model
for the role of Pin1 in AD progression is as follows: neuroprotective functions of
Pin1 are lost as age-related oxidative stress inhibits Pin1, allowing the formation
of neurofibrillary tangles and B-amyloid deposits, which then accelerate the loss
of Pin1 function by sequestering it to the insoluble fraction. In order to prevent or
reverse this pathological loss of Pin1 activity, it is necessary to determine the
biochemical mechanism of Pin1 inhibition by oxidation.

1.4

Oxidative stress and protein modification
The role of oxidative stress in the development of many aging-related

pathologies, including Alzheimer’s disease, is well established.48 One of the main
12

sources of oxidative stress in neurodegeneration in general, and AD in particular,
is the mitochondria. 49 Studies have correlated the increased oxidative damage in
AD neurons with mitochondrial lysis.50 One of the major redox products
generated by cellular respiration in the mitochondria is hydrogen peroxide (H2O2),
a redox molecule capable of a variety of protein modifications, and implicated in
many redox signaling pathways.51 One of the major peptide targets of H2O2 is the
thiol group (-SH) on the side chain of cysteine. H2O2 undergoes an SN2 reaction
with cysteine-SH to produce cysteine sulfenic acid (Cys-SOH), which generally
serves as a transition state in the development of other oxidative modifications of
cysteine.52,53 As outlined in Figure 1-3, these include the formation of disulfide
bonds, and further SN2 reactions with either backbone amines, or H2O2, to form
sulfenylamides, or sulfinic (-SO2H) and sulfonic (-SO3H) acid.
As outlined above, the catalytic pocket of Pin1 contains a cysteine residue
with a low pKa, which increases its nucleophilicity, making it likely to partake in
an SN2 reaction with H2O2.54-57 Given that this cysteine is implicated in the
catalytic mechanism of Pin1 isomerization, this would suggest that Pin1 enzyme
activity could be sensitive to oxidative stress.

13

Figure 0-3. Hydrogen peroxide-mediated oxidation of cysteine.
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1.5

Objective
The loss of Pin1 activity is implicated in the development of Alzheimer’s

disease, and evidence suggests that Pin1 is oxidized in the hippocampus of
patients developing AD. The biochemistry of Pin1 isomerase activity suggests
that Pin1 may be sensitive to oxidative stress at the catalytically critical Cys113
residue. It was therefore hypothesized that Pin1 is inhibited by oxidative
modification of Cys113. This was tested first by establishing that Pin1 is
inhibited by H2O2 using an assay of peptidyl-prolyl isomerase activity. It was
then determined that Cys113 was modified by oxidation, using a chemical tag
specific to unmodified thiol groups. The oxidation-mediated inhibition of Pin1
was then shown to be dependent on the presence of Cys113, using a catalytically
active Pin1 mutant lacking that residue. X-ray crystallography was then
performed to determine the structure of oxidized Pin1, and the presence of the
oxidative modification found in the crystal structure was confirmed in vitro by
mass spectrometry and further isomerase assays. The validation of this
hypothesis reinforces the theory that the loss of Pin1 function due to oxidation
plays a role in the development of Alzheimer’s disease.

15

2
2.1

Materials and Methods

Protein expression and purification.
Recombinant R14A Pin1 and R14A C113D Pin1 were expressed in BL21

E. coli carrying pProEX-HTA plasmids generously provided by Dr. Brian Shilton.
Individual colonies were grown to an OD of 0.6 in L Broth with 100 µg/mL
ampicillin (Roche) at 37 ºC, then expression was induced overnight at 18 ºC with
0.6 mM isopropylthio-α-ᴅ-β-galactoside. Bacteria were pelleted and resuspended
in HEPES buffer (10 mM HEPES, 100 mM NaCl, 5 mM NaN3, pH 7.4) with
protease inhibitors (1 mM phenylmethylsulfonyl fluoride, 10 µg/mL pepstatin A,
and 10 µg/mL leupeptin), then lysed by sonication. The soluble fraction of
bacterial lysate was separated by centrifugation. The soluble lysate was loaded
onto a 5 mL HisTrap HP nickel sepharose affinity column (GE Healthcare Life
Sciences). The column was washed with 20 column volumes of HEPES buffer
containing 10 mM imidazole, followed by 10 column volumes of 50 mM
imidazole, both of which were collected for quality assessment of the expression
and purification. His-tagged Pin1 was eluted in 500 mM imidazole – generally
over the course of 2 column volumes, though protein content of the eluent was
monitored by A280 using the ÄKTA FPLC system (GE Healthcare Life Sciences).
The protein concentration of the eluted solution was determined by A280, TEV
protease was added in a stoichiometric ration of 1:25, along 5 mM DTT. This
solution was rotated at room temperature for 2 hours, followed by the addition of
a second aliquot of TEV and DTT. The resulting solution was then dialyzed three
times against at least 1 L of HEPES buffer for at least 4 hours at 4 ºC to remove
16

DTT. The solution was then loaded onto a 5 mL HisTrap column where the
flowthrough and 1 column volume of wash using HEPES buffer containing 10
mM imidazole was collected. This solution was dialyzed twice against 1 L of
HEPES buffer containing 1 mM EDTA and 5 mM DTT for at least 4 hours at 4 ºC
to remove imidazole, followed by once against HEPES buffer with no additives.
Purified R14A Pin1 in HEPES buffer was concentrated to 15 mg/mL using an
Amicon Ultra centrifugal filter tube and flash frozen for storage at -80 ºC.

2.2

Oxidation of Pin1.
Oxidation of Pin1 was done by adding H2O2 to a final concentration of

either 500 µM or 1 mM when preparing the 20 µM stock solution of Pin1. This
was incubated for the reported duration (between 30 minutes and 4 hours) at 4 ºC
before beginning the assay in question. For subsequent treatment with DTT,
H2O2 was decomposed by adding 400 units of catalase at room temperature for 15
minutes, followed by 10 mM DTT for 30 minutes.

2.3

Peptidyl-prolyl isomerase assays.
Peptidyl prolyl isomerase assays were performed using recombinant Pin1

and a previously published protocol.10,58 A stock solution of R14A Pin1 at 20 µM
was prepared in the HEPES buffer defined above. The substrate, succinyl-AEPFp-nitroanaline, was dissolved in LiCl/TFE (0.3 M LiCl dissolved in
trifluoroethanol) to a stock concentration of 10 mM. Chymotrypsin (Type II,
17

Sigma-Aldrich) was dissolved in 1 mM HCl to a concentration of 50 mg/mL.
Assays were carried out at 0 ºC using a Cary-100 spectrophotometer, measuring
absorbance at 405 nm. Prior to beginning a run, 1.9 mL of HEPES buffer, minus
the volume of substrate stock to be added, was mixed with the appropriate volume
of substrate stock in a cuvette with a stirrer. Multiple runs were collected with
varying concentrations of substrate, to a maximum of 250 µM. Data collection
was started prior to the addition of chymotrypsin. 50 µL of chymotrypsin stock
solution was added, and the burst phase and subsequent chemical isomerization
rate were observed as changes in absorbance over time. Once the rate was linear,
50 µL of Pin1 stock solution was added, and the run was allowed to continue until
all substrate had been consumed, as indicated by the absorbance progress curve
reaching a slope of zero. From the absorbance progress curve of each run, the
initial rate of Pin1-mediated absorbance change was calculated by subtracting the
slope of the linear region of the curve immediately prior to the addition of Pin1
(the chemical isomerization rate) from the slope of the linear region of the curve
immediately following Pin1 addition, and converted to measure of concentration
per time using using Beer’s law, with an ε for pNA at 405 nm of 6026 cm-1 M-1.
The absorbance just prior to Pin1 addition was subtracted from the final
absorbance to give an absorbance due to the cis isomer of the substrate peptide,
which was used to determine the concentration of the cis isomer (the substrate
isomerized by Pin1). The initial rate of Pin1-mediated change in substrate
concentration, as calculated above, directly corresponds to isomerization by way
of the subsequent isomer-specific proteolysis by chymotrypsin. The plot of this
18

value ( v0 ) against substrate concentration, calculated above, can be fit to the
linear reduction of the Michaelis-Menten equation, v0 =

k cat
[ E ]0 [ S ] , which is
KM

applicable when [substrate] ᴅ KM. Thus kcat/KM was determined by dividing the
slope of this line, which corresponds to

k cat
[ E ]0 , by the final concentration of
KM

Pin1 in the assay.

2.4

Protein thiol counting assay.
Thiol counting by reaction with dithiodipyrimidine (DTDP) was done

using recombinant Pin1 and an established protocol.59 Absorbance readings were
taken at 324 nm. For each experiment, the spectrophotometer was zeroed with
120 µL of 20 µM Pin1 in HEPES buffer at pH 7.0. After zeroing, 5 µL of 4 mM
DTDP in 12 mM HCl was added, and the cuvette was then immediately vortexed.
A324 readings were taken after incubating for 5 minutes at room temperature. The
absorbance of a reagent control (A324r), consisting of 120 µL of HEPES buffer
with 5 µL of 4 mM DTDP, was also collected. The concentration of thiol groups
in the solution was determined by the following equation, where ε324 = 21400 cm1

M-1 and

= 1 cm:
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2.5

Crystallization of R14A Pin1.
R14A Pin1 was crystallized by hanging drop vapour diffusion over 3 days

in 2.0 to 2.4 M ammonium sulfate, 1% (v/v) poly(ethylene glycol) 400 (PEG400)
and 100 mM HEPES at pH 7.8 and 4 °C. Oxidized crystals were grown as above,
with mother liquor containing 10 mM H2O2.

2.6

X-ray data collection and refinement.
Data was collected using a laboratory source and processed using

MOSFLM and Scala.60,61 Structure solution and refinement was done by
molecular replacement in PHENIX using 2ITK as the starting model for the
untreated R14A Pin1 structure. 62,63 The oxidized Pin1 structure was solved by
molecular replacement using the untreated structure as the starting model, and
topology file CSW.cif from REFMAC5.64

2.7

ESI mass spectrometry.
Pin1 samples were analyzed using Q-TOF Ultima API (Waters, Milford,

MA), with MassLynx V4.1 for analysis and data processing (The capillary
voltage, 3 kV; cone voltage, 60 V; RF lens 1 voltage, 40 V; source temperature,
80 °C; desolvation temperature, 250 °C. The cone and desolvation gas flow rates
were 50 and 500 L/h, respectively) coupled to a Waters UPLC pump at a flow rate
of 200 µL min-1, using a water/acetonitrile gradient in the presence of 0.1 %
formic acid.
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2.8

K-means clustering analysis.
Clustering analysis of the isomerase rescue data was done using SciKit

Learn, a python-based machine learning library.65 The sklearn.cluster.KMeans
class was initialized with n_clusters = 3, and the fit(X) method was run on a 3dimensional array of isomerase activity vs. H2O2 concentration vs. duration of
treatment. The K-means clustering algorithm is formally described as follows:

2.9

Statistics.
All statistics were computed in Prism6 (Graphpad Software), using the

analyses and n-values indicated in the respective figures.
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3
3.1

Results

Pin1 is inhibited by oxidation.
The objective of this study is to investigate the mechanism in which Pin1

is inhibited by oxidation. First, the inhibitory effect of oxidation on Pin1, as first
reported by Sultana et al., will be examined.47 Modification of the thiol of the
active-site cysteine 113 is hypothesized to be the cause of oxidation-mediated
inhibition of Pin1. This hypothesis will be tested by comparing the effects of
oxidation between wild-type Pin1 and a Pin1 mutant lacking a thiol in the active
site. The structure of oxidized Pin1 will be solved to determine whether the
active site cysteine is modified by oxidation. Finally, the potential functional
implications of this redox modification of cysteine 113 will be explored.
In order to examine the effect of oxidation on Pin1 structure and function,
it was first necessary to assess the conditions under which Pin1 is inhibited by
oxidation, as first demonstrated by Sultana et al.47 To do this, an in vitro
spectrophotometric assay of isomerase activity was used to compare the activity
of reduced versus oxidized Pin1.10,58,66 In brief, Pin1 isomerase activity is tracked
by an increase in the concentration of the chromophore p-nitroanaline in solution
by measuring absorbance at 410 nm. The p-nitroanaline is present in the assay
solution as part of a peptide substrate that undergoes a cis-trans isomerization
catalyzed by Pin1, followed by cleavage by the trans-specific protease
chymotrypsin. The slope of the resulting absorption progress curve gives both the
chemical and total isomerization rates of the peptide, thereby allowing for the
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determination of the Pin1-catalyzed rate of isomerization of the substrate at a
certain concentration of substrate. By repeating this assay with low
concentrations of the peptide relative to its Km, the linear initial slope of a
Michaelis-Menten plot can be determined, thereby allowing Kcat/Km values to be
determined for Pin1.
Purified human Pin1 contain a substitution of Arg14 to alanine (R14A
Pin1) was used for this and all subsequent experiments to represent wild-type
Pin1, as the R14A mutation has no discernible effect on substrate binding or
enzyme activity, while allowing for the growth of more stable crystals for x-ray
crystallography.63,67 As seen in Figure 3-1, the Kcat/Km of reduced R14A Pin1
with the substrate peptide succinyl-AEPF-pNA is approximately 336 +/- 57 mM1 -1

s , which is consistent with recombinant Pin1 activity values in the literature.10,58

Oxidation of Pin1 was performed in vitro by pre-incubating 20 µM Pin1 with 500
µM or 1 mM H2O2 (corresponding to molar ratios of 25:1 or 50:1 of H2O2 to
Pin1) for 4 hours at 4 °C. Activity of oxidized Pin1 was significantly inhibited by
both treatments (P = 0.0019 by one-way ANOVA and Tukey’s multiple
comparison post-test), with isomerase activity almost 100-fold lower than that of
untreated Pin1. This result confirmed that Pin1 is strongly inhibited by oxidation.
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Figure 3-1. Pin1 is inhibited by oxidation.
Isomerase activity of R14A Pin1 was determined by a spectrophotometric assay
using the peptide substrate succinyl-AEPF-p-nitroanaline.10 20 µM Pin1 was preincubated with 500 µM or 1 mM H2O2 for 4 hrs prior to the assay. ** P ≤ 0.01 by
one-way ANOVA and Tukey’s multiple comparison post-test, n = 3.
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3.2

Oxidation of Pin1 modifies cysteine thiol groups.
Cysteine 113 of Pin1 has previously been implicated in catalysis, and is

predicted to be ionized at physiological pH due to its low predicted pKa.10 Low
pKa cysteine is generally a target of oxidation from a variety of sources, including
hydrogen peroxide.54-57 The thiol sidechain of cysteine is susceptible to oxidative
modification by H2O2 to sulfenic, sulfinic, and sulfonic acid – the addition of one,
two, or three oxygen molecules to the sulfur, respectively68 In order to determine
whether the thiol of Cys113 is modified during oxidation-mediated inhibition of
Pin1, a cysteine-counting reagent, 4’4’-dithiodipyridine (DTDP), was used to
spectrophotometrically monitor the loss of unmodified thiols while inhibiting
Pin1 with H2O2.59 Though Pin1 has two cysteine residues at positions 57 and 113,
Cys57 is not solvent-accessible in either of two representative crystal structures
(1PIN or 1F8A) as determined by the European Bioinformatics Institute’s
macromolecular interface software suite, PDBePISA.3,67,69 It was therefore
expected that only Cys113 would react with DTDP in the untreated sample,
whereas the oxidized samples would show no reaction with DTDP. As seen in
Figure 3-2, untreated R14A Pin1 shows one reactive thiol group per Pin1
molecule, consistent with the solvent accessibility analysis. A mutant of R14A
Pin1 was used as a negative control, in which Cys113 was substituted for aspartic
acid (C113D Pin1). Untreated R14A C113D Pin1 showed no reactive thiol
groups per protein molecule. Treatment of 20 µM R14A Pin1 with either 500 µM
or 1 mM H2O2 for 4 hours, as above, lowered the availability of reactive thiol to
levels not significantly different than the negative control (P = 0.6 and P ≥ 0.99 by
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one-way ANOVA and Tukey’s multiple comparison post-test). This implies that
the solvent-exposed thiol group of Cys113 is modified by oxidation. Since
Cys113 is involved in catalysis, oxidative modification of this residue may
directly affect Pin1 enzyme activity.
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Figure 3-2. Oxidation of Pin1 modifies cysteine side-chain thiol groups.
The effect of oxidation on the number of cysteine thiol groups available for
reaction with 4,4'-dithiodipyridine (DTDP).59 As above, 20 µM Pin1 was preincubated with 500 µM or 1 mM H2O2 for 4 hrs followed by incubation with
DTDP for 5 minutes at room temperature. Absorbance was measured at 324 nm,
and after substracting relevant controls, concentration of reacted cysteine was
determined using literature values for ∆ε324. *** P ≤ 0.001 and **** P ≤ 0.0001
by one-way ANOVA and Tukey’s multiple comparison post-test, n = 6.

27

3.3

Oxidation-mediated inhibition of Pin1 is dependent on Cys113.
To determine whether the loss of isomerase activity due to oxidation of

Pin1 is due to oxidation of Cys113, the isomerase activity assay shown in Figure
3-1 was repeated using Pin1 with an aspartic acid substitution at Cys113. C113D
Pin1 has been shown to retain approximately 30% of wild-type catalytic
activity,10 and aspartic acid is considerably less susceptible to hydrogen peroxidemediated oxidation than cysteine,70 so it was expected to retain activity after
treatment. As seen in Figure 3-3, the same oxidation treatments that caused 100fold inhibition of wild-type Pin1, 500 µM and 1 mM H2O2 for 4 hours, had no
significant effect on the catalytic activity of the C113D mutant (P = 0.78 and P =
0.61 by one-way ANOVA and Tukey’s multiple comparison post-test). This
suggests that oxidative modification of Cys113 is directly responsible for
oxidation-mediated inhibition of Pin1, since mutation of that residue to a
catalytically-active aspartic acid rescues Pin1 isomerase activity under identical
oxidation conditions.
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Figure 3-3. Oxidation-mediated inhibition of Pin1 is dependent on Cys113.
R14A C113D Pin1 isomerase activity was measured spectrophotometrically using
succinyl-AEPF-p-nitroanaline as in Figure 3-1. Activity of the C113D mutant of
Pin1 has been shown to be approximately 30% of that of wild-type Pin1.10 As in
Figure 3-1, 20 µM R14A C113D Pin1 was pre-incubated with 500 µM or 1 mM
H2O2 for 4 hrs prior to the assay. R14A C113D Pin1 isomerase activity was not
significantly different after treatment with 500 µM or 1 mM H2O2. R14A Pin1
treated H2O2 from the same stock solution is shown as a positive control. ** P ≤
0.01 by one-way ANOVA and Tukey’s multiple comparison post-test, n = 3.
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3.4

Oxidation of Pin1 results in sulfinylation of Cys113.
The structural modification of Cys113 by hydrogen peroxide was

investigated using X-ray crystallography. Crystals of reduced R14A Pin1 were
grown in hanging drops in 2.10 M ammonium sulfate, 1% (v/v) poly(ethylene
glycol) 400 (PEG400) and 100 mM HEPES at pH 7.8 and 4 °C. After 3 days,
crystals of the space group P3121 appeared. The crystal diffracted to 2.03 Å, and
the structure was solved by molecular replacement using the published Pin1
structure 2ITK (with ligand deleted), which has the same space group and unit
cell geometry.63 The structure of reduced R14A Pin1 was very similar to
published structures, with an RMSD of 0.180 Å when aligned to the Pin1
structure 2ITK. See Table 3-1 for structure statistics.
In order to obtain structures of oxidized Pin1, crystals were grown as
above with various concentrations of H2O2. The largest crystal formed in 2.4 M
ammonium sulfate, 1% PEG400, and 10 mM H2O2 after 3 days, and was also of
the P3121 space group. The crystal diffracted to 1.86 Å, and the structure was
solved using molecular replacement with the reduced R14A Pin1 structure above.
Overall, the structure was very similar to the reduced R14A Pin1 structure, with
an RMSD after alignment of 0.137 Å.
In order to determine whether the protein structure of the oxidized crystal
contained any oxidative modifications, the observed electron densities of the
untreated and oxidized crystals were compared using an isomorphous difference
map of |Fo(oxidized)|-|Fo(untreated)| (Figure 3-4a). Both of the largest positive
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and negative differences centered around Cys113, at 10.06 and -6.32 sigma,
respectively. The crescent-shaped “ripples” of positive and negative differences
in electron density indicate a difference in positioning between the atoms in the
two structures, while the larger peak of positive density versus the surrounding
negative density suggests a difference in occupancy, specifically that the oxidized
structure has higher electron occupancy in that area. Overlaying the refined
model from oxidized Pin1 crystal shows the positioning difference between
Cys113 in each crystal, and that this slight torsion of the oxidized structure is
localized to Cys113 and Ser114, with an RMSD between these pairs of residues
of 0.49 Å (Figure 3-4b).
Refinement of the oxidized crystal structure resulted in further evidence of
a modification at Cys113. By comparing the 2|Fo|-|Fc| maps from the refined
structures of untreated R14A Pin1 (Figure 3-5a) and R14A Pin1 crystallized in
10 mM H2O2 (Figure 3-5b), the differences highlighted in the |Fo|-|Fo| map can be
seen. While electron density around the γ sulfur of the cysteine side chain of the
untreated structure is larger than that of the β carbon, as expected for the larger
sulfur atom, the oxidized structure has a much larger, pyramidal density. The |Fo||Fc| map shows a bi-lobed region of positive density around the two corners of the
pyramidal shape not occupied by the sulfur of the model. Since cysteine sulfinic
acid is a product of cysteine oxidation, and the two oxygen atoms bound to the
sulfur of the sulfinic acid form a pyramidal geometry, cysteine sulfinic acid was
modelled into this site. As seen in Figure 3-5c, the resulting refined structure
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showed no electron density unaccounted for in the |Fo|-|Fc| map around the sulfinic
acid.
Cysteine and methionine are the two amino acids most susceptible to
oxidation by hydrogen peroxide. However, none of the other cysteine or
methionine residues in the refined Pin1 structure from the oxidized crystal
showed excess density in the |Fo|-|Fc| map, suggesting that Cys113 is the most
susceptible to oxidation (Figure 3-6a-d). Furthermore, as noted above, the two
structures of Pin1 overlay almost perfectly, with an RMSD of 0.137 Å, with only
the termini of each domain, and the Cys113 and Ser114 regions showing changes
in backbone position (Figure 3-6e).
The specific oxidation of Cys113 to irreversible cysteine sulfinic acid
shown in this crystal structure suggests that this residue is most readily oxidized,
and this modification directly results in the inhibition of Pin1.

32

Table 3-1. Crystallographic
data collection and refinement
Resolution range (Å)
Space group
Unit cell
Total reflections
Unique reflections
Multiplicity
Completeness (%)
Mean I/sigma(I)
Wilson B-factor
R-merge
R-meas
R-work
R-free
Number of atoms
macromolecules
ligands
water
Protein residues
RMS(bonds)
RMS(angles)
Ramachandran favored
Ramachandran outliers
Clash score
Average B-factor
macromolecules
ligands
solvent

Untreated R14A Pin1
47.55 - 2.042
(2.115 - 2.042)
P3121
68.65 68.65 79.23
90 90 120
26098 (2060)
13691 (1143)
1.9 (1.8)
96.83 (83.13)
9.64 (2.13)
25.83
0.04061 (0.3017)
0.05743
0.1953 (0.2847)
0.2453 (0.3752)
2529
1155
24
190
145
0.012
1.31
98%
0.71%
6.14
26.1
24.8
28
34.4
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R14A Pin1
+ 10 mM H2O2
29.62 - 1.863
(1.929 - 1.863)
P3121
68.4 68.4 79.29
90 90 120
35843 (3197)
18247 (1653)
2.0 (1.9)
99.04 (90.87)
21.13 (6.03)
20.53
0.02349 (0.1144)
0.03322
0.1767 (0.2267)
0.2102 (0.2580)
2517
1157
24
181
145
0.011
1.27
97%
0.71%
3.07
26.2
25
19.4
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Figure 3-4. Difference maps of the untreated and oxidized R14A Pin1 crystals.
(A) Crystal structure of untreated R14A Pin1 at 2.04 Å with a 2|Fo|-|Fc| map (blue)
contoured at 1.0 sigma, and an |Fo|-|Fo| map (green/red) contoured at 3.0 sigma.
The two highest magnitude peaks were 10.06 and -6.32 sigma, and are shown as
labelled grey stars. (B) As above, with R14A Pin1 crystallized with 10 mM H2O2
at 1.86 Å (light grey and pink backbone) aligned with untreated R14A Pin1 (dark
grey and cyan backbone). Images were created using The PyMOL Molecular
Graphics System, Version 1.6.0.0 Schrödinger, LLC.
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Figure 3-5. Crystal structures of untreated and oxidized R14A Pin1.
(A) The untreated R14A Pin1 crystal structure at 2.04 Å with a 2|Fo|-|Fc| map
(blue) contoured at 1.0 sigma, and |Fo|-|Fc| maps (green/red) contoured at 3.0
sigma. The Cys113 residue from Pin1 crystallized in the absence of H2O2,
showing an electron density typical of a sulfur atom, with no unmodelled density.
(B) The crystal structure of R14A Pin1 crystallized with 10 mM H2O2 at 1.86 Å
with a 2|Fo|-|Fc| map (blue) contoured at 1.0 sigma, and |Fo|-|Fc| maps (green/red)
contoured at 3.0 sigma. The Cys113 sulfur of Pin1 crystallized in the presence of
10mM H2O2 shows extra electron density in a bi-lobed shape, suggesting two
extra atoms bound to the cysteine sulfur. (C) After addition of cysteine sulfinic
acid at position 113, refinement of the oxidized Pin1 structure showed no electron
density unaccounted for in the |Fo|-|Fc| map around position 113. Images were
created using The PyMOL Molecular Graphics System, Version 1.6.0.0
Schrödinger, LLC.
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Figure 3-6. Oxidative modification of Pin1 is specific to Cys113.
Cysteine and methionine are the two amino acids most susceptible to oxidation by
H2O2. Met15 (A), Cys57 (B), Met130 (C), and Met146 (D) show no positive
electron density in the |Fo|-|Fc| map. (E) An overlay of the untreated R14A Pin1
structure and structure of R14A Pin1 crystallized in the presence of 10 mM H2O2,
with an RMSD of 0.137 Å. The side chain of the cysteine sulfinic acid is shown,
and the surface is coloured according to temperature factor of the oxidized
structure. Images were created using The PyMOL Molecular Graphics System,
Version 1.6.0.0 Schrödinger, LLC.
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3.5

Hydrogen peroxide treatment of Pin1 for isomerase assays
parallels treatment of Pin1 crystals.
The concentration of hydrogen peroxide used to oxidize R14A Pin1 in

crystals was necessarily lower than that used in in vitro assays, since the
timeframe of exposure was days instead of hours. This makes it difficult to draw
parallels between the in vitro isomerase data and the crystal structure. In order to
assess the structural modifications to R14A Pin1 resulting from the in vitro H2O2
treatment, ESI mass spectrometry was used to accurately measure intact protein
mass. R14A Pin1 was oxidized by 1 mM H2O2 for 4 hours as in the isomerase
assays above, and analysed using Q-TOF ESI mass spectrometry. The resulting
data (red trace) was compared to data from analysis of untreated R14A Pin1
(black trace), as seen in Figure 3-7a. The peak corresponding to R14A Pin1
shifted 32 Da after treatment. This mass is corresponds to two oxygen molecules,
which is consistent with the oxidative modification of Cys113 to cysteine sulfinic
acid as seen in the crystal structure. This indicates that the H2O2 treatments used
in crystal formation and in in vitro assays have the same structural effects.
Cysteine sulfinic acid is a chemically-irreversible oxidative modification
of cysteine, while the less stable cysteine sulfenic acid can be reduced back to
cysteine by a variety of reducing agents including dithiothreitol (DTT).71 In order
to determine whether cysteine sulfenic acid or sulfinic acid is the cause of the
inhibition seen in vitro, the isomerase assay from Figure 3-1 was repeated after
attempting to reverse the inhibition by exposure to DTT. As above, 20 µM Pin1
was incubated with 1 mM H2O2 for 4 hours at 4 °C, then the H2O2 was
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decomposed by adding 400 units of catalase at room temperature for 15 minutes,
followed by 10 mM DTT for 30 minutes. The isomerase assay showed no
significant rescue of catalytic activity of Pin1 after treatment with DTT (P = 0.93
by one-way ANOVA and Tukey’s multiple comparison post-test), as seen in
Figure 3-7b. Therefore the H2O2 treatment resulting in the in vitro inhibition of
Pin1 for these isomerase assays is causing irreversible oxidation of Cys113 to
sulfinic acid, as shown in the crystal structure above.
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Figure 3-7. H2O2 treatment of Pin1 for isomerase assays parallels crystal
structure treatment.
(A) ESI mass spectrometry analysis of untreated R14A Pin1 (black trace) and
R14A Pin1 treated with 1 mM H2O2 for 4 hours (red trace), as in Figure 3-1.
Recombinant R14A Pin1 shows one major peak at 17583 Da, and upon oxidation,
that peak shifts 32 Da to 17615 Da. This mass change corresponds to the two
additional oxygen molecules of cysteine sulfinic acid, as shown in Figure 3-5c.
(B) Isomerase activity of R14A Pin1 as in Figure 3-1. 20 µM Pin1 was preincubated with 1 mM H2O2 for 4 hrs, then quenched by adding 400 U of catalase
for 15 minutes, followed by 10 mM DTT for 30 minutes. Treatment with DTT
showed no significant increase in activity compared to the oxidized sample (P >
0.5 by one-way ANOVA and Tukey’s multiple comparison post-test), while all
treatments showed significantly reduced activity compared to the untreated
sample, which suggests that Cys113 is irreversibly oxidized to cysteine sulfinic
acid with this treatment. ** P ≤ 0.01 by one-way ANOVA and Tukey’s multiple
comparison post-test, n = 3.
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3.6

Oxidation-mediated inhibition of Pin1 is reversible.
An interesting result appeared in the process of ensuring that the hydrogen

peroxide treatment used in the in vitro activity assays resulted in the same
oxidative modification as seen in the crystal structure. When performing the
isomerase assays on R14A Pin1 pretreated with 500 µM H2O2, it was found that
contrary to the results above, treating with 10 mM DTT for 30 minutes rescued
30% of isomerase activity relative to untreated R14A Pin1. This suggested that
30% of Cys113 residues in the Pin1 sample were not being oxidized to sulfinic
acid, but rather to its unstable reducible precursor, sulfenic acid. This is an
interesting finding, as it opens the door to the possibility of regulation of Pin1
isomerase activity by physiological redox mechanisms. To investigate this
further, it was hypothesized that with shorter durations of H2O2 treatment, a larger
percentage of Cys113 in the Pin1 sample would be oxidized to sulfenic acid,
thereby inhibiting Pin1 activity, but allowing for rescue of activity after reduction
with DTT. Figure 3-8a shows that partial rescue of Pin1 isomerase activity was
possible by reducing the duration or concentration of hydrogen peroxide
treatment. Similar to above, Pin1 was treated for 4 hours or less with 500 µM
H2O2, or 1 hour or less of 1 mM H2O2, then H2O2 was decomposed by adding
catalase. This was followed by 30 minutes of 10 mM DTT treatment, after which
isomerase assays showed that treated samples had 30-45% of activity relative to
untreated R14A Pin1. This result suggests that the less stable, reducible oxidation
product of cysteine, sulfenic acid, is forming at lower H2O2 treatments, albeit not
universally.
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It is also notable that for a specific subset of conditions, varying the
duration or concentration of H2O2 treatment has no effect on the degree of DTTmediated rescue. Efficacy of rescue did not vary more than 15% for treatments
between 30 minutes and 4 hours at 500 µM H2O2, or between 30 mintues and 1
hour at 1 mM H2O2. Linear regression analysis of those data plotted as a function
of activity versus exposure time showed that the slope of the resulting line was
not significantly deviated from zero (P = 0.87), implying that exposure time had
no significant effect on rescue, over that time frame. By looking at the graph in
Figure 3-8a, it appears as though the efficacy of rescue drops in a stepwise rather
than linear manner as concentration and duration of H2O2 treatment increases.
To assess the validity of the observation that there are discrete differences
in the response of Pin1 to varying treatments of hydrogen peroxide, rather than a
continuous linear trend, K-means clustering analysis was used.65 K-means
clustering is a simple unsupervised machine learning algorithm that attempts to
group data based only on its proximity to each cluster’s centroid. The algorithm
works by iteratively assigning a centroid values for each putative cluster, then
partitioning the data to minimize the within-cluster sum of squares (a measure of
distance between the centroid and each data point assigned to it), until optimal
positions of centroids and partitioning of data has been achieved.
As shown in Figure 3-8b, K-means clustering of the data from Figure 38a, plotted as isomerase activity versus H2O2 concentration versus duration of
treatment separated the data into three groups: fully active (in purple), partially
active (in cyan), and inactive (in red). All samples treated with H2O2, but not
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DTT, were labelled as inactive, while the untreated samples were labelled as fully
active. All samples treated with both H2O2 and DTT, except those treated with 1
mM H2O2 for 2 and 4 hours clustered together as partially active, meaning that
their activities were nearer to each other than the activities of the fully active or
inactive samples. The clusters were significantly different by one-way ANOVA
and Tukey’s multiple comparison post-test (P < 0.0001). The information from
these two analyses suggests that the Pin1 sample has discrete responses to varying
levels of oxidative stress. At a certain threshold concentration and duration of
H2O2 exposure, in this case between 1-2 hours at 1 mM H2O2, the whole Pin1
sample population is irreversibly oxidized, suggesting that in all molecules
Cys113 is modified to cysteine sulfinic acid. Whereas below that threshold (less
than 1 hour at 1 mM H2O2, or 4 hours or less at 500 µM H2O2) 30-45% of Cys113
in the Pin1 sample is oxidized but reducible, suggesting that it is modified to
cysteine sulfenic acid. While further investigation of the significance of discrete
nature the response of Pin1 to oxidation, it is apparent that Pin1 isomerase activity
may be reversibly regulated by oxidation.
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Figure 3-8. Inhibition of Pin1 by oxidation is partially reversible.
Isomerase activity of R14A Pin1 as in Figure 3-1, with DTT treatments as in
Figure 3-7. 20 µM Pin1 was pre-incubated with 500 µM or 1 mM H2O2 for up to
4 hrs, then quenched by adding 400 U of catalase for 15 minutes, followed by 10
mM DTT for 30 minutes. (A) DTT treatment had a significant effect on all
oxidation treatments except for the untreated control, and treatments of 1 mM of
H2O2 for 2 or 4 hours. * P ≤ 0.05 by paired T-tests, n = 3. (B) K-means
clustering analysis of the above data 65. ● is without DTT, and ■ is those treated
with 10 mM DTT. The colours represent the clusters assigned by the K-means
algorithm, with fully active in purple, partially active in cyan, and inactive in red.
The clusters were significantly different by one-way ANOVA and Tukey’s
multiple comparison post-test (P < 0.0001).
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4
4.1

Discussion

Pin1 in neurodegeneration.
The peptidyl-prolyl isomerase Pin1 has diverse roles in a number of

human diseases, and is consequently of interest to the field of medical research.
In cancer, its role in proliferation makes it a potential therapeutic target, while in
dementias, its ability to reverse some of the neurodegenerative pathologies is of
interest.72 Given that Pin1 has been shown to be neuroprotective, an effort has
been made to understand why it cannot effectively perform that role in
neurodegenerative diseases such as Alzheimer’s disease (AD). While there is
little evidence to suggest that there is a genetic link, or that Pin1 expression
changes in AD 38-42, it has been shown that Pin1 availability and subcellular
localization is negatively affected by AD pathologies. Pin1 associates with both
neurofibrillary tangles and amyloid plaques in AD neurons, and this causes a
reduction in the soluble fraction of Pin1, and a change in localization from the
nucleus to cytoplasm.30,31,43,44 Since Pin1 has been shown to prevent or reverse
both of these pathologies, there must be another mechanism by which Pin1
activity is lost prior to AD onset.23,27
A series of oxidative proteomics studies of Mild Cognitive Impairment
(MCI)46 and AD47 brain tissue by the Butterfield lab demonstrated that Pin1 is
significantly oxidized in aging brain and this oxidation negatively impacts Pin1
enzymatic activity.. In both MCI and AD hippocampal samples, Pin1 was shown
to have lower activity than in age-matched controls, and by treating purified Pin1
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with hydrogen peroxide in vitro, it was shown that loss of isomerase activity
could be attributed to oxidation. These studies established a role for Pin1 in the
progression of Alzheimer's disease; the neuroprotective functions of Pin1 are lost
as age-related oxidative stress inhibits Pin1, allowing the formation of
neurofibrillary tangles and B-amyloid deposits which accelerate the loss of Pin1
function by sequestering it to the insoluble fraction. In order to prevent or reverse
this pathological loss of Pin1 activity, it is necessary to determine the biochemical
mechanism of Pin1 inhibition by oxidation.

4.2

Pin1 is inhibited by oxidation.
To elucidate the biochemical mechanism of oxidation-mediated inhibition

of Pin1, it was first necessary to determine the in vitro conditions in which Pin1 is
effectively inhibited by oxidation. One of the Butterfield group’s studies assayed
oxidation-mediated inhibition of Pin1 isomerase activity in vitro. In their study,
55 nM of purified Pin1 was treated with 1 mM H2O2 for 3 hours, resulting in 60%
activity versus the untreated sample.47 As shown in Figure 3-1, purified R14A
Pin1 was treated with either 500 µM or 1 mM H2O2 for 4 hours at 4 ºC, which
resulted almost complete loss of activity (2% activity versus the untreated
sample). Reducing the length of H2O2 exposure to 2 hours did not change the
extent of inhibition, as seen in Figure 3-8a. In principle these results are
consistent with the findings of the Butterfield group, both show that Pin1 is
inhibited by oxidation. However, the difference between the modest reported
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inhibition in their study and the robust inhibition shown here may be due to
limitations inherent in the methodology used to determining isomerase activity.
The chymotrypsin-linked spectrophotometric assay of isomerase activity
used in both this study and previous studies of Pin1 oxidation was first developed
by Fischer et al. in 1984, with the critical finding that chymotrypsin cleaves
proline-containing substrates in an isomer-specific manner, therefore allowing the
amount of cis to trans isomerization of a substrate to be monitored.73 Kofron et
al. furthered the assay by addressing the complication of non-enzymatic
isomerization of the substrate.66 As the population of trans isomer of the
substrate is consumed, an event termed the “burst phase”, non-enzymatic
isomerization of the substrate occurs in order to redress the shift in isomer
distribution from equilibrium. Since any trans substrate subsequently produced is
rapidly cleaved by chymotrypsin, this non-enzymatic isomerization rate remains
steady, until all substrate is consumed. Kofron et al. ran a series of control
experiments to determine the first-order rate constant for this isomerization, in
order to account for this when calculating PPIase dependent isomerization rates.
Given that the substrates they used were optimized for chymotrypsin cleavage,
and the concentration of chymotrypsin in the assay was high, the product of the
isomerization reaction was assumed to be immediately cleaved by chymotrypsin.
This allowed the rate of PPIase-mediated isomerization to be calculated from each
absorbance progress curve using the integrated rate equation derived by Kofron et
al., which included the rate constant of non-enzymatic isomerization.
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In order to have enough data to fit to this model, Kofron et al. recognized
the need to increase the relative concentration of substrate with cis-proline. Their
other major contribution to the development of this assay, therefore, was to
develop a non-aqueous buffer that shifts the cis-trans equilibrium of the substrate
such that up to 60% of substrate is in the cis isomer. The buffer, consisting of
lithium chloride dissolved in trifluoroethanol (LiCl/TFE), not only meant that the
absorbance progress curve better fit the integrated rate equation, but also allowed
for assaying with wider range of substrate concentrations. Consequently, the
assay could be used to fit Michaelis-Menten models of inhibition, as well as
simple kinetics.66
The isomerase assay was further modified by Behrsin et al. in 2007 to
better control for the non-enzymatic isomerization rate, and address the concern
that significant proteolysis of Pin1 over the course of the assay could affect
results.10 That study controlled for non-enzymatic isomerization of the substrate
internally during each experimental run by monitoring the absorbance change due
to the initial burst of trans-substrate cleavage, and subsequent steady rate of
isomerization prior to adding Pin1 to the system. This can be seen in Figure 41a, a sample trace from the current study, which uses the same methodology as
Behrsin et al. At position 1, the substrate in LiCl/TFE has just been added to the
aqueous assay buffer in the spectrophotometric cuvette. After gathering baseline
absorbance data, chymotrypsin is added (position 2). The “burst phase”, in which
chymotrypsin rapidly cleaves all trans substrate, is clearly visible, followed by a
steady-state rate of non-enzymatic isomerization. After this steady state has been
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achieved, Pin1 is added to the cuvette (position 3), and the isomerization rate
from this point forward is a combination of Pin1-mediated and non-enzymatic
isomerization of substrate, which is monitored until all substrate has been
consumed in order to accurately calculate the initial concentration of cis peptide.
In order to shorten run times, thereby reducing the impact of proteolysis
on the results, Behrsin et al. opted not to use the integrated rate equation from
Kofron et al. to determine isomerization rate from the absorbance progress curve
of each run. The integrated rate equation was used to account for the changing
ratio of non-enzymatic contribution to the substrate isomerization rate as substrate
is consumed. By using only the linear portions of the absorbance progress curves,
specifically the boxed region of Figure 4-1a, corresponding to the steady-state rate
of non-enzymatic isomerization and the initial combined rates of Pin1-mediated
and non-enzymatic isomerization, Behrsin et al. eliminated the need for the
integrated rate equation by simply subtracting the slope of one linear section from
the other, as in Figure 4-1b. The slope of the blue line represents the rate of nonenzymatic isomerization, while the slope of the orange line represents the initial
rate of Pin1-mediated isomerization combined with the rate of non-enzymatic
isomerization. By subtracting these values, the initial rate of Pin1-mediated
isomerization ( v0 ) is determined. By determining v0 at a number of substrate
concentrations in which [cis-substrate] ᴅ KM, the resulting [cis-substrate] vs. v0
plot can be fit to the linear reduction of the Michaelis-Menten equation:

v0 =

k cat
[ E ]0 [ S ] , as seen in Figure 4-1c.
KM
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Figure 4-1. An sample response curve for the spectrophotometric isomerase
assay.
(A) The response curve in its entirety. Before beginning, the appropriate
concentration of succinyl-AEPF-p-nitroanaline is added to the buffer solution in
the cuvette. 1. Data collection begins in order to get a baseline value for
determination of the total substrate concentration. 2. Chymotrypsin is added, and
immediately begins cleavage of trans substrate, releasing p-nitroanaline and
causing an increase in absorbance at 410 nm. Once chymotrypsin has cleaved all
available trans peptide, the absorbance curve levels off, though the slope remains
positive, representing the rate of chemical isomerization of the peptide. 3. Pin1 is
added after the curve has become linear. During the period of time in which Pin1
is saturated by substrate, the slope of the absorbance curve is linear, and
represents the sum of the rates of chemical and Pin1-catalysed isomerization. As
Pin1 and chymotrypsin consume substrate, the absorbance curve levels off until
all substrate is consumed. The absorbance at 3 is subtracted from this absorbance
to determine the concentration of peptide when Pin1 was added. (B) This figure
is the boxed section of the response curve from (A). The slopes of the blue and
orange lines represent the chemical and chemical + Pin1-mediated isomerization
rates, respectively. The former is subtracted from the latter to determine the Pin1catalyzed isomerization rate. (C) The Pin1 isomerization rate is determined at a
number of substrate concentrations, and these data are plotted as Pin1
isomerization rate (mM/s) versus substrate concentration (mM). The resulting
slope (s-1) is divided by the concentration of Pin1 to determine the Kcat/Km (mM1 -1
s ).
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The critical difference between the results of this study and those of the
Butterfield lab is that while the latter showed a reduction in Pin1 isomerase
activity to 60% of the untreated control, almost identical treatments of hydrogen
peroxide yielded 2% isomerase activity in the current study. The Butterfield lab
cites Kofron et al.66 and Schutkowski et al.74 as sources for their PPIase assay
technique, while Schutkowski et al. cite Fischer et al.73 as the source of their
assay.47 Based on this, one could assume that they used substrate peptides
dissolved in LiCl/TFE, ran a chymotrypsin-only control, and used the integrated
rate equation to account for the contribution of non-enzymatic isomerization to
the change in absorbance monitored by the assay. However, while the isomerase
assay is only briefly outlined in their methods, it is noted that the substrate peptide
was dissolved in DMSO. Kofron et al. showed that the ratio of cis isomer in
peptides dissolved in DMSO was approximately 10%,66 whereas in their
LiCl/TFE buffer that climbed to 40-60%. The increase in the dynamic range of
the absorbance progress curve afforded by the higher proportion of cis isomer in
substrates dissolved in LiCl/TFE allowed Kofron et al. to determine v0 using the
integrated rate equation, thereby appropriately controlling for non-enzymatic
isomerization in their assay. The Butterfield lab studies mention neither avoiding
collecting the “burst phase” in the absorbance progress curve, as in Kofron et al.,
nor addressing the contribution of steady-state non-enzymatic isomerization of
substrate to the apparent activity displayed in their assay’s absorbance progress
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curve. While the steady-state non-enzymatic isomerization rate may be relatively
low compared to untreated Pin1-mediated isomerization rates, the “burst phase”
in the absorbance progress curve is not, as seen in Figure 4-1a after position 2.
Since the isomerase assay used by the Butterfield group does not temporally
separate this “burst phase” from monitoring the change in absorbance due to Pin1mediated isomerization, as done in Behrsin et al.,10 there is a risk that this may
have affected the calculation of the Pin1-mediated isomerization rate in that assay.
It is therefore possible that the lack of inhibition due to oxidation seen by the
Butterfield group is due to overlooked non-enzymatic isomerization of the
substrate.
If this is the case, the finding that Pin1 is inhibited by oxidation impacts a
variety of neurodegenerative diseases. Using the same isomerase assay, the
Butterfield lab also showed that in the hippocampus of AD patients’ brains, Pin1
activity was approximately 60% compared to that of age-matched controls.47 The
same lab also showed that Pin1 in hippocampal homogenates of MCI patients was
shown to have 90% activity compared to age-matched normal hippocampal
samples.46 Given that the assay used in these experiments underestimates the
degree of inhibition of isomerase activity, this indicates that the oxidationmediated inhibition of Pin1 shown in vitro in this study is paralleled in
neurodegenerative disease. In order for this information to be of therapeutic
value, however, it is important to understand the molecular cause of this
inhibition.
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4.3

Oxidation of Pin1 modifies cysteine thiol groups.
A common mechanism for redox regulation of proteins is through

modification of a thiol group, especially that of a cysteine residue with a low
pKa.54-57,71 While this commonly results in disulfide formation, recent studies
have shown that oxidative modification of active-site cysteine residues can result
in the formation of other oxidation products, and consequently modify protein
activity.55,75,76 In order to determine whether cysteine thiol groups of Pin1 are
modified by oxidation, a simple method used to count cysteine thiol groups was
used. The reagent 4’4’-dithiodipyridine (DTDP) behaves similarly to Ellman’s
reagent in that it reacts with cysteine thiols to release a chromophore that can be
monitored spectrophotometrically.59 The concentration of the reaction product, 4thiopyridone, which has maximal absorbance at 324 nm, is directly correlated to
the concentration of unmodified cysteine in solution. By comparing this to the
concentration of protein in solution, a count of unmodified cysteine residues per
protein molecule can be calculated. As seen in Figure 3-2, untreated R14A
C113D Pin1 (negative control) contains no solvent-exposed cysteine residues,
while untreated R14A Pin1 (positive control) has one. While Pin1 has two
cysteine residues, Cys57 and Cys113, Cys57 is buried in the properly folded
protein.3,67 Therefore it was expected that R14A C113D Pin1 shows no reactivity
with DTDP, since it only contains Cys57, while R14A Pin1 has one solventexposed thiol on Cys113. Treatment with hydrogen peroxide significantly
decreased the availability of reactive thiols on R14A Pin1 to levels not
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significantly different than the negative control. Therefore oxidation is modifying
the thiol group of Cys113 of Pin1.

4.4

Oxidation-mediated inhibition of Pin1 is dependent on Cys113.
Cys113 of Pin1 is located in the active site of the isomerase domain, and

has been implicated in catalysis. Early structural studies proposed a nucleophilic
role for this residue, similar to that of a cysteine protease.3 It was proposed that
the nearby His59 deprotonates Cys113, resulting in nucleophilic attack by the
thiolate on the carbonyl carbon of the substrate. The resulting high-energy
tetrahedral intermediate would then be released, potentially changing its isomeric
conformation. Subsequent studies, however, demonstrated that a covalent
interaction between Pin1 and its substrates was unlikely. First, solution NMR
studies of a Pin1 homolog showed none of the chemical shifts expected for
covalent interaction when incubated with a substrate.77 Secondly, mutational
analysis identified a catalytically active Pin1 mutant containing an aspartic acid
substitution at position 113, as well as a conserved hydrogen-bonding network
around Cys113.10,78 These studies instead reinforced an alternative theory, which
proposes that Pin1 catalyzes isomerization of the peptide bond by placing the
substrate carbonyl oxygen in a negatively charged environment, weakening the
double-bond character of the peptide bond and allowing it to rotate. Though the
literature is still divided between these two mechanisms, it is apparent that
Cys113 is both physically near to substrates and chemically important to their
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Pin1-catalyzed isomerization. It is therefore likely that oxidation-mediated
inhibition of Pin1 involves this cysteine thiol.
In order to determine whether oxidation-mediated inhibition of Pin1 is
dependent on oxidation of Cys113, isomerase assays were performed using a
recombinant Pin1 enzyme containing a catalytically active C113D mutation
(R14A C113D Pin1). While cysteine is susceptible to oxidation by hydrogen
peroxide, aspartic acid is much more resistant to oxidative stress. Oxidation of
aspartic acid is generally caused by irradiation, and results in beta-scission of the
side chain to form glyoxylic acid.70 If oxidation-mediated inhibition occurs due
to modification of Cys113, it is predicted that isomerase activity of R14A C113D
Pin1 will be unaffected by hydrogen peroxide. As hypothesized, Figure 3-3
shows that oxidation of R14A C113D Pin1 by H2O2 has no significant effect on
isomerase activity. This indicates that Cys113 is modified by oxidation, blocking
its ability to participate in catalysis.

4.5

Oxidation of Pin1 results in sulfinylation of Cys113.
Oxidation of cysteine thiols can result in a wide variety of modifications

with varying characteristics, as outlined in Figure 1-3. Homodimerization via
disulfide bonding is the classic example of biological oxidation of thiols. The
prototypical redox sensor in cells is glutathione (GSH), a tripeptide that forms a
disulphide-linked homodimer upon oxidation. GSH acts as a cellular redox
buffer, as it is reduced by glutathione reductase and NADPH.71,79,80
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Intermolecular disulfide bonding is also a common result of oxidation of thiols
and plays a critical structural role in most secreted proteins.71,81 Intermolecular
disulfide bond formation is also possible. Despite the overall reducing
environment of the cytoplasm, a number of proteins have been shown to
reversibly cross-link via disulfide bonds in an H2O2-dependent manner,
suggesting a role for disulfide bonding in H2O2-mediated signalling.82 Other
oxidative modifications of cysteine thiol groups have also been shown to regulate
various enzymes. Protein tyrosine phosphatases are a family of cysteinedependent phosphatases involved in a number of signaling mechanisms.
Oxidation of the low pKa catalytic cysteine of protein tyrosine phosphatase PTP1b
has been shown to regulate its activity in the insulin response signaling cascade.76
Oxidation of this residue by hydrogen peroxide results in the formation of a
reversible sulphenyl-amide bond with the backbone amine of the following
residue and subsequent inhibition of phosphatase activity. More recently, redox
regulation of the family of ovarian tumor (OTU) deubiquitinases has been
identified.75 These cysteine proteases are also inhibited by hydrogen peroxide,
which reversibly oxidizes the low pKa catalytic cysteine to cysteine sulfenic acid.
Even cysteine sulfinic acid, which is not chemically reducible, is found in redox
regulation. Sulfiredoxin is an enzyme that catalyzes the reduction of cysteine
sulfinic acid in the antioxidant enzyme family of 2-Cys Peroxiredoxins,
regenerating their ability to reduce hydrogen peroxide in cells.83 Finally, cysteine
sulfonic acid is the result of further oxidation of sulfinic acid, and is also
irreversible.
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In order to determine how Cys113 of Pin1 is modified by oxidation, R14A
Pin1 was co-crystallized with H2O2 and the presence of structural modifications to
Cys113 were determined by comparison of the x-ray diffraction data with that of
untreated R14A Pin1. After solving the structure of untreated R14A Pin1 at 2.04
Å, the electron density maps generated from the x-ray diffraction data of the
untreated and H2O2-treated crystals were compared, as seen in Figure 3-4a. This
analysis subtracts the electron density map of the oxidized crystal from that of the
untreated crystal. If the structures were identical, there would be very little
differences in electron density, which are shown in green (positive density,
attributable to the oxidized protein) and red (negative density, from the untreated
protein). The majority of the protein structure shows no difference in electron
density, while highest magnitude peaks in both positive and negative difference
maps occur around Cys113 suggesting that this residue is different in the oxidized
structure. Interpretation of the pattern of positive and negative densities in the
difference map indicates two things: that the γ-sulfur of Cys113 is not aligned in
the two structures, and that there may be extra electron density associated with it
in the oxidized structure. Initial refinement of the oxidized structure reinforced
the former conclusion. Overall, the two structures aligned very well after
refinement, with an RMSD of 0.137 Å, but Cys113 and Ser114 were shifted
slightly in the oxidized structure (local RMSD of 0.49 Å) to allow the γ-sulfur of
Cys113 to move to the centre of the large positive density in the difference map.
Consistent with the conclusions from the difference map, the |Fo|-|Fc| map used to
assess the quality of the refined structure of oxidized Pin1 revealed positive
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electron density around the γ-sulfur of Cys113, as shown in Figure 3-5b. This
map subtracts the electron density predicted by the modelled structure (Fc) from
the electron density calculated from the x-ray diffraction data (Fo). The positive
map (in green) is the result of observed density not accounted for by the refined
model. In this case, the bi-lobular shape of the positive density suggests two
atoms are bound to the γ-sulfur of Cys113. Further refinement after replacing
Cys113 with cysteine sulfinic acid showed that the two oxygen molecules account
for this extra density and there is no unaccounted density around position 113 in
the final refined structure.
To determine whether oxidative modification of Pin1 is isolated to
Cys113, the other susceptible sulfur-containing residues of Pin1 were investigated
as above. Both the difference map and the refined structures indicated neither the
three solvent-exposed methionine residues nor the buried Cys57 were oxidized in
the H2O2-treated crystal structure, as shown in Figure 3-6(a-d). While the
specificity of oxidative modification of Pin1 is impressive, it is not unexpected.
The average predicted pKa of Cys113 in all Pin1 structures deposited in the
Protein Data Bank (www.pdb.org) is at least two orders of magnitude lower than
that of Cys57, and low pKa cysteines are generally the protein residues most
susceptible to oxidation.71,84 As noted earlier, the local chemical environment
causing the low pKa of Cys 113 is presumed to be necessary for catalysis, as it
causes the cysteine thiol to carry a partial or full negative charge. It would seem
that susceptibility to oxidative stress is simply a by-product of that enzymatic
mechanism.
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4.6

Hydrogen peroxide treatment of Pin1 for isomerase assays
parallels crystal structure treatment.
In order to draw conclusions regarding the effects of oxidation on Pin1

isomerase activity from the crystal structure of oxidized R14A Pin1, it was
necessary to confirm that the hydrogen peroxide treatment used in cocrystallization had the same structural effects as that used in the in vitro assays.
Intact protein Q-TOF ESI mass spectrometry was used to accurately measure the
mass change of Pin1 due to oxidation. As seen in Figure 3-7a, the mass of R14A
Pin1 increases by 32 daltons, which corresponds to two oxygen atoms, after the
same H2O2 treatments used in vitro. This would indicate that the in vitro H2O2
treatment results in modification of Cys113 to cysteine sulfinic acid, as in the
crystal structure. This conclusion was confirmed by attempting to rescue
isomerase activity of oxidized R14A Pin1 by reduction using dithiothreitol
(DTT). Figure 3-7b shows oxidation-mediated inhibition of R14A Pin1 by 1 mM
H2O2 for 4 hours is irreversible. Since cysteine sulfinic acid is not reducible, this
result confirms that this H2O2 treatment results in oxidation of Cys 113 to cysteine
sulfinic acid.

4.7

Loss of Pin1 isomerase activity in neurodegenerative
pathologies is due to oxidation of Cys113.
Redox proteomics studies of the hippocampus of patients with Mild

Cognitive Impairment (MCI) and Alzheimer’s disease (AD) have shown that Pin1
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is oxidized in both of these conditions.46,47 These studies identified proteins as
oxidized on the basis of the presence of peptide carbonyl derivatives.85 The
generation of peptide carbonyl derivatives, or carbonylation, is generally the
result of metal-catalysed oxidation or severe oxidation and can occur at most
amino acids.70 The non-specific effects of carbonylation make it a convenient
tool for redox proteomics studies, and also allow for comparison between the data
from this in vitro study and the in vivo studies implicating oxidized Pin1 in
neurodegenerative pathologies. Since oxidative modification of cysteine to
cysteine sulfinic acid requires less oxidative stress than the generation of peptide
carbonyl derivatives, it follows that the Pin1 identified as carbonylated in MCI
and AD hippocampal samples would contain oxidized Cys113. This would imply
that Pin1 from AD hippocampal samples should exhibit the same degree of
oxidation-mediated inhibition demonstrated in the current study. However, the
studies of Pin1 oxidation in MCI46 and AD47 brain undertaken by the Butterfield
lab show only modest inhibition by oxidation. One study even shows in vitro data
that exhibits a similarly modest degree of Pin1 inhibition to the in vivo samples,
despite using almost the same H2O2 treatment as in Figure 3-1, where isomerase
activity is abolished by oxidation.47 Returning to the comparison of isomerase
assay data between this study and those of the Butterfield lab, this is further
evidence to suggest that the assay technique used in those studies underestimated
the degree of inhibition due to oxidation. The current study therefore reinforces
the findings of the Butterfield group, that Pin1 is inactivated by oxidation in
Alzheimer’s disease. Furthermore, this study demonstrates that oxidation65

mediated inhibition of Pin1 is caused by modification of Cys113 to cysteine
sulfinic acid, a modification that requires a minimal degree of oxidative stress
compared to carbonylation.
MCI is considered a clinical precursor to symptomatic AD.45 Butterfield
et al. identified Pin1 as carbonylated in MCI hippocampal samples, and showed
that Pin1 isomerase activity in these samples was modestly reduced compared to
age matched controls.46 As above, the findings of the current study suggest that
the isomerase activity assay of Butterfield et al. underestimated the decrease in
isomerase activity in the MCI samples. These data suggest that Pin1 is inhibited
by oxidation in the hippocampus of AD patients at or before the onset of their
neurological symptoms, as defined by an MCI diagnosis.
Adding the conclusions of this study to those of previous redox studies of
Mild Cognitive Impairment and Alzheimer’s disease hippocampal tissue provides
increased evidence for the validity of the model proposed at the beginning of this
chapter. As outlined in a recent review of the subject, an aging-related increase in
oxidative stress causes the loss of Pin1 isomerase and thus a loss of the
neuroprotective roles of Pin1, including the prevention of Alzheimer's pathologies
such as B-amyloid deposition and the formation of neurofibrillary tangles.86 The
implication of this work is that the inhibition of Pin1 isomerase activity caused by
oxidation of Cys113 occurs prior to the onset of Alzheimer’s disease, and may
play a role in its progression.
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4.8

Oxidation-mediated inhibition of Pin1 is reversible.
While the goal of this study was to explore the structural basis for the

oxidation-mediated inhibition of Pin1 in Alzheimer’s disease, a serendipitous
result revealed another interesting aspect of redox effects on Pin1. While
attempting to rescue Pin1 isomerase activity by reduction using dithiothreitol
(DTT), it was noted that while treatment with 1 mM H2O2 for 4 hours results in
irreversible oxidation, halving the concentration of H2O2 allows for modest
rescue. This effect was explored by varying the duration of H2O2 treatments, as
shown in Figure 3-8a. Even at 1 mM H2O2, shorter durations of treatment
allowed for modest rescue of isomerase activity by reduction of Pin1. However,
once below the threshold required for irreversible inhibition, neither concentration
of H2O2 nor duration of treatment changed the efficacy of rescue of isomerase
activity. This observation was confirmed by analyses that showed that there was
no non-zero correlation between these inputs and the change in isomerase activity,
and that the behaviour of Pin1 isomerase activity in response to the varying
treatments clustered in discrete and significantly different groups corresponding
to inactive, fully active, and partially active isomerase activity. The latter group
was composed entirely of data points from treatments including rescue by DTT.
In order for Pin1 isomerase activity to be rescued by reduction of the oxidized
Cys113, that residue must have been modified to the less stable cysteine sulfenic
acid rather than sulfinic acid. The fact that 30-45% of isomerase activity is
rescued over a range of treatments suggests that a distinct and persistent subset of
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Pin-1 sample population is able to maintain the unstable sulfenic acid moiety at
Cys113, while the remaining molecules are further oxidized to sulfinic acid.
It has been proposed that the hydroxyl of cysteine sulfenic acid must
participate in hydrogen bonding in order to prevent further oxidation to
irreversible sulfinic acid.75 Hydrogen peroxide-mediated oxidation of cysteine to
sulfenic acid and subsequent oxidation reactions are essentially SN2 reactions
requiring a nucleophilic thiolate or sulfenyl group.52,53 Hydrogen bond pairing
between the sulfenic acid and a nearby hydrogen bond donor reduces the
nucleophilicity of the sulfenyl, preventing further oxidation by H2O2. Figure 42a shows that the ovarian tumor deubiquitinase family stabilizes cysteine sulfenic

acid in its catalytic pocket this way, thereby allowing these proteases to be
regulated to hydrogen peroxide. Pin1 and its evolutionarily ancient homologs
maintain a complex hydrogen bonding network in the isomerase domain active
site, as shown in Figure 4-2b.69,78 This hydrogen bonding network is essential to
Pin1 function and has been hypothesized to maintain Cys113 in an ionized or
partially charged state.10 A thiolate group on Cys113 does not have a proton
available to accept a hydrogen bond from the carbonyl of the substrate peptide,
allowing Cys113 to destabilize the carbonyl anion that occurs in the double-bond
resonance state of the substrate peptide bond. This hydrogen bonding network
may also have the added effect of stabilizing the reversible cysteine sulfenic acid
oxidation product of Cys113, allowing Pin1 isomerase activity to be reversibly
regulated by oxidation.
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If His59 is acting as a hydrogen bond donor to stabilize cysteine sulfenic
acid in position 113 of oxidized Pin1, one would expect this effect to be uniform
throughout the sample of Pin1, or at least affected in a linear fashion by the
severity of oxidative stress in the system. However, this study has shown that
over a range of H2O2 treatments, a distinct and persistent subset of the Pin1
population is capable of stabilizing cysteine sulfenic acid, while the remainder is
not. Assuming stability of sulfenic acid is dependent on hydrogen bonding, this
suggests that only 30-45% of the ε2 nitrogen of His59, which is proximal to
Cys113, is capable of acting as a hydrogen bond donor in these conditions.
Histidine is a complex amino acid which exists in a number of pH dependent
ionic and tautomeric states. Li & Hong recently undertook a rigorous
characterization of these states, and some of their structural characteristics.87 As
shown in Figure 4-2c, the histidine tautomer in which Nε2 can act as a hydrogen
bond donor exists only at high pH. However, the average predicted pKa of His59
in all Pin1 structures deposited in the Protein Data Bank (www.pdb.org) was
approximately 3, whereas normally histidine has a pKa of approximately 7.84 This
suggests that the equilibrium for the various states of histidine at this residue is
shifted, allowing some of the His59 amino acids in the Pin1 population to adopt
the π tautomer, thereby allowing Nε2 to serve as a hydrogen bond donor, and
stabilizing sulfenic acid.
This hypothesis seems inconsistent with the Pin1 enzyme model in which
His59 Nε2 is a required hydrogen bond donor for maintaining a thiolate at Cys113
to catalyze isomerization. However, more recent structural studies have shown
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that the dual-histidine motif in the Pin1 isomerase domain active site does not
play a role in catalysis of isomerization.14 Recombinant Pin1 in which both His59
and His157 were substituted with leucine (H59L/H157L Pin1) was capable of
maintaining viability in yeast, where the isomerase activity of Pin1 or its yeast
analogue Ess1 is necessary for viability. The pKa of Cys113 was predicted to be
unchanged by these mutations, suggesting that the anionic nature of Cys113 was
unchanged and that it was sufficient for catalysis of isomerization.84 Thus the
isomerase activity of Pin1 is not dependent on the tautomeric state of His59. In
that study, it was concluded that the dual histidine motif plays a structural role
and may have a role in the dynamics of the Pin1 catalytic pocket.14 Since these
two histidines are evolutionarily conserved,10 they must have some importance to
the physiological functions of Pin1 yet that role is currently not convincingly
characterized. The current study has revealed that oxidation-mediated inhibition
of Pin1 is reversible and that this reversibility may be dependent of the
availability of His59 for hydrogen bonding. The specificity of oxidative
modification of the active-site Cys113, along the evolutionary conserved His59dependent reversibility of the subsequent inhibition, suggests that Pin1 may be
physiologically regulated by hydrogen peroxide. This would add Pin1-mediated
signalling pathways to the emerging field of redox regulation, further reinforcing
the need for a global survey of potential redox-regulated enzymes.
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Figure 4-2. Hydrogen bonds stabilize the cysteine sulfenic acid.
(A) Hydrogen bonding to backbone amine and a nearby His stabilizes the cysteine
sulfenic acid in OUT deubiquitinases. Adapted from Kulathu et al., 2013 75. (B)
The network of hydrogen bonds in the Pin1 isomerase domain active site, shown
in oxidized Pin1 containing cysteine sulfinic acid. His59 and both the backbone
amine and sidechain hydroxyl of of Ser115 can participate in hydrogen bonding
with the Cys113 thiol group. The extensive network is hypothesized to help
maintain the Cys113 thiol in a partially or full negatively charged state 10. Images
were created using The PyMOL Molecular Graphics System, Version 1.6.0.0
Schrödinger, LLC. (C) The various ionic and tautomeric forms of histidine, and
their equilibrium constants. Adapted from Li and Hong, 2011 87.
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4.9

Future considerations.
In order to better understand the biochemical requirements for redox

regulation of Pin1, dependence of this phenomenon on hydrogen bonding to
His59 should be established. In order to assess this, further isomerase activity
rescue assays are needed to compare a His59-deficient mutant with wild-type
Pin1, together with x-ray crystallography experiments to determine a structure for
Pin1 with cysteine sulfenic acid. Alternative modalities for Cys113-dependent
redox regulation should also be explored, specifically the possibility of
intermolecular disulfide bonding as a mechanism of Pin1 inhibition in cells.
Finally, the effects of sulfenylation of Cys113 of Pin1-substrate interactions
should be evaluated, using a previously established pulldown technique.
Isomerase activity rescue assays using recombinant Pin1 proteins
containing His59 mutations should be used to assess the importance of His59dependent hydrogen bonding on cysteine sulfenic acid stability. Bailey et al.
demonstrated that both H59Q and H59L/H157L Pin1 have isomerase activity,
allowing the former to be used as a positive control for the availability of
hydrogen bonding with cysteine sulfenic acid and the latter as a negative.14 The
isomerase activity rescue assays could be used to compare the effects of DTT on
H2O2-mediated inhibition between wild-type, H59Q ( which can form hydrogen
bonds), and H59L/H157L Pin1 (which cannot). In order to explore the
importance of His59 tautomerization on cysteine sulfenic acid stabilization, the
assays could be repeated at varying pH, dependent on the functional pH range of
the assay. At more basic pH, the π tautomer of His59 should predominate,
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thereby potentially improving the effects of DTT on isomerase activity. The
findings from these assays should guide the hydrogen peroxide treatment used to
attain the crystal structure of Pin1 with cysteine cysteine sulfenic acid. Since this
moiety has been identified in other x-ray crystallography experiments, it should
be attainable.75
Since the current study was limited to in vitro techniques, it is possible
that an alternative mechanism for redox regulation was overlooked, specifically
the possibility of intermolecular disulfide bonding. The potential for this process
in the redox regulation of Pin1 could be assessed by modifying the techniques
outlined by Cumming in 2008.88 Specifically, Pin1 would be overexpressed in
cultured cells which would then then be subjected to treatment with H2O2. After
isolating Pin1 complexes from the lysates in non-reducing conditions by
immunoprecipitation, the resulting solution would be separated by SDS-PAGE,
and interacting proteins identified by mass spectrometry.
As outlined in the introduction, a current focus of this lab is the various
binding modalities of Pin1. Given the potential steric hinderance of cysteine
sulfenic acid during substrate interaction with the Pin1 isomerase domain, it
would be interesting to explore the binding properties of oxidized Pin1. This
could be performed using a similar pulldown technique to that of Innes et al.,9
comparing those proteins interacting with oxidized Pin1 to those of the isomerase
binding-deficient mutant, R68A/R69A Pin1, and wild-type. The different
substrate interaction patterns for wild-type and oxidized Pin1 could yield insights
into the potential functional roles of redox regulation of Pin1.
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These proposed experiments assess the validity of the hypothesis that
stabilization cysteine sulfenic acid requires a proximal hydrogen bonding partner.
If this is demonstrated to be the case, this would reinforce the model proposed by
Kulathu et al.,75 in which low pKa cysteines with a nearby hydrogen bond donor
may be the target of oxidation-mediated sulfenylation, thereby making them
possible candidates for physiological redox regulation. This model could guide
the search for other enzymes undergoing redox regulation. The workflow would
be as follows:
1. Using an annotated database of structures deposited in the protein
data bank, identify proteins with solvent exposed cysteines.89
2. Using publish pKa prediction software, identify those cysteines
which have sufficiently low pKa values to be considered
susceptible to oxidation.84
3. Either using a simple vector search algorithm, or simply measuring
vector distances between every potential hydrogen bond-donating
atom in the protein and the γ-sulfur of the low pKa cysteine,
determine whether an appropriate hydrogen bonding partner is
available for each cysteine.
4. Finally, determine whether the identified cysteine is important for
catalysis for each successful enzyme.
The validity of the resulting list could be assessed by selecting one or
more enzymes predicted to be redox regulated, and assaying their enzyme activity
following treatment with H2O2 and subsequent rescue by DTT.
75

The field of redox regulation is growing with the development of more
effective and accessible techniques for analysis of redox modification. However,
the focus has thus far been on identifying oxidized proteins in tissues and
pathologies, the results of which may be overlooked by the enzymology
community. By applying a set of criteria for global assessment of the molecular
impact of redox regulation, the proposed experiments seek to trigger a new front
in the progression of the redox regulation field, driven by biochemical studies of
enzyme activity, in order to establish redox regulation as another important
cellular signaling mechanism.
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